Chris Labaki takes us through his study evaluating temporal changes in the screening, diagnosis, and surgical treatment of genitourinary malignancies during the first year of the COVID-19 pandemic.
Research from three countries adds support for the use of a booster dose of vaccines against SARS-CoV-2 in people with cancer, especially those undergoing active anticancer treatment.
Two papers from the prospective, longitudinal UK CAPTURE consortium shed light on the humoral and cellular immune response to SARS-CoV-2 vaccination and infection in patients with cancer.